Article Text

PDF
AB0007 Shared genetic predisposition in rheumatoid arthritis–interstitial lung disease and familial pulmonary fibrosis
  1. PA Juge1,
  2. R Borie2,
  3. C Kannengiesser3,
  4. S Gazal3,
  5. P Revy4,
  6. L Wemeau-Stervinou5,
  7. MP Debray6,
  8. S Ottaviani1,
  9. S Marchand-Adam7,
  10. N Nathan8,
  11. G Thabut9,
  12. C Richez10,
  13. H Nunes11,
  14. I Callebaut12,
  15. A Justet2,
  16. P Richette13,
  17. H Lioté14,
  18. Y Allanore15,
  19. O Sand16,
  20. C Dromer17,
  21. RM Flipo18,
  22. A Clément8,
  23. J Sibilia19,
  24. B Coustet1,
  25. V Cottin20,
  26. MC Boissier21,
  27. B Wallaert22,
  28. T Schaeverbeke10,
  29. DLM Florence8,
  30. A Frazier13,
  31. C Ménard23,
  32. M Soubrier24,
  33. N Saidenberg21,
  34. D Valeyre11,
  35. S Amselem8,
  36. C Boileau3,
  37. B Crestani2,
  38. P Dieudé1
  1. 1Rheumatology
  2. 2Pulmonology A
  3. 3Genetic, Hopital Bichat
  4. 4INSERM UMR_1163, Paris
  5. 5CHRU de Lille, Lille
  6. 6Radiologie, Hopital Bichat, Paris
  7. 7CHU de Tours, Tours
  8. 8Pneumologie pédiatrique, Hôpital Trousseau
  9. 9Pulmonology B, Hopital Bichat, Paris
  10. 10Rheumatology, CHU Bordeaux, Bordeaux
  11. 11Pulmonology, Hôpital Avicenne, Bobigny
  12. 12CNRS UMR_7590
  13. 13Rheumatology, Hôpital Lariboisière
  14. 14Pulmonology, Hôpital Tenon
  15. 15Rheumatology, Hôpital Cochin, Paris
  16. 16UMR_8199, Lille
  17. 17CHU Bordeaux, Bordeaux
  18. 18Rheumatology, CHRU de Lille, Lille
  19. 19Rheumatology, CHU de Strasbourg, Strasbourg
  20. 20UMR_754, Lyon
  21. 21Rheumatology, Hôpital Avicenne, Bobigny
  22. 22Pulmonology, CHRU de Lille
  23. 23UMR_s933, Paris
  24. 24CHU Clermont Ferrand, Clermont Ferrand, France

Abstract

Background Despite its high prevalence and mortality, little is known about the pathogenesis of RA–associated interstitial lung disease (RA-ILD). Given that familial pulmonary fibrosis (FPF) and RA–ILD frequently share the usual interstitial pneumonia pattern and common environmental risk factors, we hypothesized that the two diseases may share additional risk factors including FPF-linked genes.

Objectives Our aim was to identify coding mutations of FPF-risk genes associated with RA-ILD.

Methods We used whole-exome sequencing (WES) followed by restricted analysis of a discrete number of FPF-linked genes and performed a Burden test to assess the excess number of mutations in RA–ILD patients compared to controls.

Results Among the 101 RA–ILD patients included, 12 (11.9%) had 13 WESidentified heterozygous mutations in the TERT, RTEL1, PARN or SFTPC coding regions. The burden test, based on 81 RA–ILD patients and 1010 controls of European ancestry, revealed an excess of TERT, RTEL1, PARN or SFTPC mutations for RA–ILD patients (p=9.45’10-4, odds ratio [OR] 3.17 95% CI 1.53 – 6.12). Telomeres were shorter for RA-ILD patients with a TERT, RTEL1 or PARN mutation than controls (p=2.87x10-2).

Conclusions Our results support the contribution of FPF-linked genes to RA–ILD susceptibility.

Disclosure of Interest None declared

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.